Environostics, Inc.

 

|   Home   |   Diagnostic Test Development   |   Contract Test Development   |   Specialty Reagents   |   Contact Information   |   About    |

Description

  • Environostics, Inc. is a privately-held R&D company ( Delaware) developing rapid diagnostic tests/assays for clients. Environostics produces prototype assays for clients, arranges for pre-clinical testing, provides antibody and colloid reagents and develops lateral flow tests using a novel platform.

Management

  • Dr. Robert Bohannon is the founder of Environostics, Inc.  Dr. Bohannon has been making rapid diagnostic tests using lateral flow, PCR, EIA and other platforms for over 15 years.  He has developed tests for detecting biowarfare agents for industry and DoD; he also developed the OraQuick HIV saliva test for Epitope (now OraSure Technologies) and developed drug of abuse tests (Sure Screen) for MedTox Diagnostics.  Dr. Bohannon holds patents on lateral flow platforms (pending and issued), PCR technologies, molecular-antibody hydrid detections methods, drug of abuse vaccines and other patents pending.  Dr. Bohannon also developed the cold gold methodology and colloidal catalyst platforms.

Investors

  • Environostics is currently self-funded. Investors/parties interested in equity or acquisition should contact Dr. Bohannon directly.